LSK Global Pharma Services

LSK Global Pharma Services ("LSK Global PS") is Korea’s largest integrated contract research organization. Founded in March 2000, it provides comprehensive services across the entire clinical development lifecycle—including consulting, regulatory affairs, study design and execution for phase I–IV trials, post-marketing surveillance studies, observational/epidemiological research and pharmacovigilance. The company has conducted over 1,600 clinical studies including more than 180 global/multinational trials as of June 2024. It was the first Korean CRO to successfully complete an international pivotal trial for an anti-cancer drug involving sites across Asia-Pacific and Europe. Its expertise spans oncology, cardiovascular disease and endocrinology among other areas.